We are live on
!
Find out more
Neumora Therapeutics
NMRA
NMRA
114 hedge funds and large institutions have $137M invested in Neumora Therapeutics in 2026 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 34 increasing their positions, 32 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
140% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 10
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
48% more call options, than puts
Call options by funds: $2.68M | Put options by funds: $1.81M
22% more capital invested
Capital invested by funds: $113M → $137M (+$24.6M)
12% more funds holding
Funds holding: 102 → 114 (+12)
4.46% more ownership
Funds ownership: 37.67% → 42.13% (+4.5%)
6% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 32
Holders
114
Holders Change
+12
Holders Change %
+11.76%
% of All Funds
1.4%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.02%
New
24
Increased
34
Reduced
32
Closed
10
Calls
$2.68M
Puts
$1.81M
Net Calls
+$863K
Net Calls Change
-$433K
Top Buyers
Top Sellers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$7.96M |
| 2 |
Millennium Management
New York
|
-$2.23M |
| 3 |
TCM
Tang Capital Management
San Diego,
California
|
-$1.37M |
| 4 |
Jane Street
New York
|
-$988K |
| 5 |
SoftBank Group
Tokyo,
Japan
|
-$880K |
